Ladenburg Thalmann Financial Services’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,575
Closed -$3K 5143
2017
Q2
$3K Hold
6,575
﹤0.01% 4546
2017
Q1
$2K Buy
6,575
+6,500
+8,667% +$3.56K ﹤0.01% 4646
2016
Q4
$0 Hold
75
﹤0.01% 5047
2016
Q3
$0 Hold
75
﹤0.01% 4964
2016
Q2
$0 Hold
75
﹤0.01% 4940
2016
Q1
$0 Hold
75
﹤0.01% 4925
2015
Q4
$0 Sell
75
-10,000
-99% -$13.9K ﹤0.01% 4880
2015
Q3
$8K Buy
10,075
+10,000
+13,333% +$11.3K ﹤0.01% 3711
2015
Q2
$0 Hold
75
﹤0.01% 4841
2015
Q1
$0 Hold
75
﹤0.01% 4728
2014
Q4
$0 Sell
75
-529
-88% -$2.62K ﹤0.01% 4516
2014
Q3
$5K Sell
604
-3
-0.5% -$25 ﹤0.01% 3435
2014
Q2
$6K Sell
607
-361
-37% -$3.08K ﹤0.01% 3342
2014
Q1
$9K Buy
968
+893
+1,191% +$5.29K ﹤0.01% 3042
2013
Q4
$0 Buy
+75
New +$351 ﹤0.01% 3928

Other funds holding BSTG

Ladenburg Thalmann Financial Services's BSTG Position: Q3 2017 in Review

Ladenburg Thalmann Financial Services sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2017, closing a stake of 6,575 shares — an estimated $3K sold.

Ladenburg Thalmann Financial Services first reported a position in BSTG in Q4 2013 and held it in 15 quarters. The position peaked at $9K in Q1 2014. 25 funds tracked by Wall St. Rank hold BSTG as of Q3 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Biostage, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 6,575 Biostage, Inc. Common Stock shares in Q3 2017, an estimated $3K.
  • Ladenburg Thalmann Financial Services first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 15 quarters.
  • Ladenburg Thalmann Financial Services's Biostage, Inc. Common Stock position peaked at $9K in Q1 2014.
  • 25 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2017, filed 15 Nov 2017.